Download

[Whitepaper] New Pharma Opportunities And Market Access Challenges In Japan

New Pharma Opportunities And Market Access Challenges In Japan 

Download this whitepaper for an essential exploration of the opportunities and challenges of clinical development in Japan.

You’ll explore topics like:

• Sources of market growth and real opportunities
• Orphan drug incentives
• New directions in pricing and reimbursement
• Recent regulatory environment
• Sales and distribution
• Market access with ICCC (in-country clinical caretaker)

Related Solutions:

Japan Market Entry/Innovative Pharma Model (IPM)

Orphan Drug

In-Country Clinical Caretaker (ICCC)

Marketing Authorization Holder (MAH)

National Health Insurance Pricing